These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22891343)

  • 21. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii.
    Tan F; Hu X; Pan CW; Ding JQ; Chen XG
    Parasitol Int; 2010 Jun; 59(2):141-6. PubMed ID: 20056166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection.
    Fouts AE; Boothroyd JC
    Infect Immun; 2007 Feb; 75(2):634-42. PubMed ID: 17088349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
    D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
    J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii.
    Roos DS
    J Biol Chem; 1993 Mar; 268(9):6269-80. PubMed ID: 8454599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.
    Gabriel G; Nordmann A; Stein DA; Iversen PL; Klenk HD
    J Gen Virol; 2008 Apr; 89(Pt 4):939-948. PubMed ID: 18343835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts.
    Garfoot AL; Wilson GM; Coon JJ; Knoll LJ
    BMC Genomics; 2019 Nov; 20(1):859. PubMed ID: 31726967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasma gondii metacaspase 2 is an important factor that influences bradyzoite formation in the Pru strain.
    Song X; Lin M; Li M; Yang X; Liu J; Liu Q
    Parasitol Res; 2020 Jul; 119(7):2287-2298. PubMed ID: 32468190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide stimulates early egress of Toxoplasma gondii tachyzoites from Human foreskin fibroblast cells.
    Yan X; Ji Y; Liu X; Suo X
    Parasit Vectors; 2015 Aug; 8():420. PubMed ID: 26264067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.
    Mitev GM; Mellbye BL; Iversen PL; Geller BL
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3700-4. PubMed ID: 19581453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.
    Stein DA
    Curr Pharm Des; 2008; 14(25):2619-34. PubMed ID: 18991679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
    Dubey JP
    Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for nuclear localisation of two stage-specific isoenzymes of enolase in Toxoplasma gondii correlates with active parasite replication.
    Ferguson DJ; Parmley SF; Tomavo S
    Int J Parasitol; 2002 Oct; 32(11):1399-410. PubMed ID: 12350375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
    Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
    Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
    Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
    Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
    Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquisition of Host Cytosolic Protein by Toxoplasma gondii Bradyzoites.
    Kannan G; Thaprawat P; Schultz TL; Carruthers VB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33504659
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
    Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
    Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.